News
Newly published research claims those taking GLP-1 jabs are at a 37 percent lower risk of dementia than those on the anti-diabetic medication.
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...
TODAY on MSN12h
Study Finds Weight-Loss Meds May Lower Dementia, Stroke RiskA new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss drugs like Ozempic and Wegovy, specifically for their potential to ...
Results from this study show that there is a direct correlation between the use of anti-obesity medications and testosterone levels,” the study author said.
Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results